STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
Stat News • 10/26/2026
Summary
Bristol Myers Squibb reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial. The news also mentions a Roche lung cancer drug and additional topics being discussed.
Advertisement
Lindy Score Breakdown (V4.2)
3h
Age
1
Sources
from cluster
1
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier99% (0.5^1/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
Stat News • 2 days ago
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
Stat News • Today
STAT+: Moderna CEO on what’s next after success in cancer vaccine
Stat News • Today
STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early
Stat News • 2 days ago
STAT+: At ESMO, AstraZeneca’s cancer pursuits get a showcase
Stat News • 1 day ago
STAT+: After a cancer vaccine’s first success, the race is on to expand the impact
Stat News • 1 day ago
STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
Stat News • Today
STAT+: Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds
Stat News • 2 days ago
Opinion: STAT readers on Elizabeth Holmes, cancer screening, and more
Stat News • 2 days ago
STAT+: Five biotech updates to read after ESMO this weekend
Stat News • Today